Skip to main content
. 2022 Oct 31;14(11):2346. doi: 10.3390/pharmaceutics14112346

Figure 4.

Figure 4

Design and responsive mechanism of hypoxia-triggered srNPs. (A) Preparation and in vivo selectively hypoxia-activated mechanism of IDMs nanomedicines for eradicating advanced breast cancer. Reproduced with permission [99]. Copyright 2021, Elsevier. (B) Chemical structure and hypoxia-responsive mechanism of NI-based nanoparticles. Reproduced with permission [98]. Copyright 2018, Royal Society of Chemistry. (C) Schematic illustration of synthesized polymers and their mechanism of hypoxia-responsive disintegration in the TME. Reproduced with permission [100]. Copyright 2014, Wiley-VCH GmbH.